Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Transcatheter aortic valve implantation: a real-life experience
Session:
Posters 4 - Écran 05 - Doença Valvular
Speaker:
Marta Braga
Congress:
CPC 2018
Topic:
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
Theme:
15. Valvular Heart Disease
Subtheme:
15.4 Valvular Heart Disease – Treatment
Session Type:
Posters
FP Number:
---
Authors:
Marta Braga; Paulo Araújo; Sofia Torres; Alzira Nunes; Roberto Pinto; Joana Duarte Rodrigues; Rui Rodrigues; Pedro Bernardo Almeida; Mariana Vasconcelos; Domingos Magalhães; JOAO SILVA; Maria Júlia Maciel Barbosa
Abstract
<p><strong>Background: </strong>Transcatheter aortic valve implantation (TAVI) is a therapeutic solution for patients with severe symptomatic aortic stenosis who are not candidate for conventional surgery. Despite its growth, TAVI is an invasive procedure in evolving and requires further refinement to reduce complications. The aim of this study was to describe the baseline characteristics and the short-outcomes in a cohort of patients referenced for TAVI procedure. </p> <p><strong>Methods: </strong>We retrospectively analysed data of a cohort of patients submitted a TAVI in a single centre, from October 2014 to December 2016. Data were collected from the electronic clinical process and registered in a uniform base.</p> <p><strong>Results: </strong>Of a total of 89 patients, 51.7% were female. Mean age of patients was 80.2±7.1 years. The prevalence of hypertension was 82.0% and of diabetes was 34.8%. Almost half of patients had obstructive coronary artery disease and 19.1% had history of cardiac surgery. Cerebral vascular disease was present in 22.5% and peripheral artery disease was diagnosed in 21.3% of the cohort. More than half of patients met criteria of chronic kidney disease. The prevalence of chronic obstructive pulmonary disease was 11.2%. Mean euroscore II was 5.7±0.5. Significant aortic calcification was present in 52.8%. Previous EKG showed first or Mobitz I second degree atrialventricular block in 74.2% of the patients and 12.3% had complete right or left branch block. Corevalve Evolute was the prothesis chosen for most patients and femoral artery was the main vascular access for the procedure. Regarding the in-hospital outcomes, 44.9% of the patients had a haemorrhagic complication peri-procedure with need of blood transfusion. Vascular complications were found in 12.4% of the patients. About 19.1% of the patients had rhythmic abnormalities requiring definite pacemaker implantation. Although 13.5% of the patients presented acute kidney failure, only 2.2% needed dialyses. Acute stroke was diagnosed in 4.5% of the patients. Moderated to severe paravalvular regurgitation was found in 2.2% of the patients. Only 1 patient died in-hospital stay.</p> <p><strong>Conclusions: </strong>Although TAVI can improve long-term outcomes of selected patients, this procedure had risks. Most TAVI complications occurred in periprocedural period and more studies are needed to understand their rate in real-world. Anticipating complications, as well as their prompt detection and management, is crucial to limiting the potential consequences of these adverse events.</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site
